Efficacy and Safety of Favipiravir in Management of COVID-19

NCT04349241 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Disease (COVID-19)

Interventions

DRUG: favipiravir
DRUG: Standard of care therapy

Sponsor

Ain Shams University